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Products  of the  K  and  D  regions  of the  murine  H-2  major  histocompatibility 
complex  serve  as  strong  transplantation  antigens  (1-4)  and  are  vital  elements  in 
associative  recognition  by  T  cells  of  viral,  chemically  modified  self  and  minor 
histocompatibility antigens  (5-10). The analysis of the role of the K, D, and L  loci in 
these  immune  responses  is  facilitated  by  the  availability  of K-,  D-,  and  L-locus 
histocompatibility  mutants.  The largest series of mutants  is that of the H-2K  b locus 
of the C57BL/6 mouse strain.  So far,  16 H-2Kb-locus mutants have been detected by 
reciprocal skin graft rejection  ([ 11-19];  R. W. Melvold. Unpublished  observations.). 
Biochemically, the K b mutations appear to be characterized by at least a single amino 
acid (AA) ~ substitution  in the K b glycoprotein ([20, 21]; B. M. Ewenstein, H. Uehara, 
T. Nisizawa, S. G. Nathenson, R. W. Melvold, and H. I. Kohn. Structural studies on 
the MHC mutants. IV. Characterization of the H-2K glycoprotein from two mutants, 
bm3  (M505,  H-2  ~)  and  bml 1 (H-2bk).  Manuscript  in preparation;  K.  Yamaga,  T. 
Nisizawa, D. McGovern, R. W. Melvold, H. I. Kohn, and S. G. Nathenson.  Unpub- 
lished  observations).  The mutations  elicit  all  of the T  cell  reactions  associated  with 
graft rejection, including positive mixed lymphocyte culture (MLC) and cell-mediated 
lympholysis (CML) reactions in vitro (22-25), as well as graft-versus-host reactivity in 
vivo (26, 27).  Studies with K b mutants have identified  the H-2K glycoprotein as the 
active element  in  K-region-associated  T  cell  recognition  of virus-infected  cells  (28- 
30).  Although early studies indicated  that the mutations are associated with little or 
no  changes  in  serologically  detectable  alloantigens,  such  changes  have  now  been 
reported  for several  members  of the  K b series  (18,  31,  32).  However,  in  reciprocal 
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immunizations with the strain of origin, no alloantibody was detected  (12,  33,  34), 
and this contrasts strongly to the ease with which T  cell reactions are elicited. 
We  now  report  studies of the  specificity of the  cytotoxic T  lymphocytes (CTL) 
generated in MLC in all possible combinations between seven Kb-locus mutants and 
the wild type H-2  b, as measured by CML. Three new K b mutants (H-2  brag, H-2  bin1°, 
and H-2  bin11) showed positive MLC and CML reactions with the strain of origin. Two 
mutants (H-2  bin6 and H-2  bmg) were  found to  be identical in CML.  The analysis of 
CML cross-reactivity against third-party targets of the K b series indicated extensive 
complexity of K b CML target-antigenic determinants. Apparently, single AA substi- 
tution in the K b molecule leads to the loss of multiple CML target determinants and 
gain of multiple new CML  target  determinants. In this  study,  64  different CML 
target  specificities were identified,  19 of which  have been described before  (25,  35, 
36). The CML antigens of the bm3 mutation, which has two AA substitutions in its 
K b glycoprotein, were closely related but not identical to those of the bm 11 mutation, 
which shares  its AA substitution with one of the two AA substitutions of bm3  (see 
above: B.  M. Ewenstein et al. Manuscript in preparation). 
Materials and Methods 
Animals.  All mice were bred at the Central Laborator~ of the Netherlands Red Cross Blood 
Transfusion Service,  Amsterdam. C57BL/6Kh (B6, H-2~ mice as well as the mutants B6-H- 
2  bin6, B6-H-2  bms, B6.C-H-2  brag, B6.C-H-2  brat°, and  B6.C-H-2  bran were  raised  from  breeding 
stocks,  supplied  by  Dr.  H.  I.  Kohn  and  Dr.  R.  W.  Melvold,  Shields  Warren  Radiation 
Laboratory, Boston, Mass.  B6.C-H  -bin1 mice were bred from stocks  supplied by Dr.  Donald 
Bailey, The,Jackson Laboratory, Bar Harbor, Maine. Breeding stock of the B6-H-2  bin3 line was 
obtained from Dr. J.  Klein, then at  the Department of Microbiology, University of Texas, 
Dallas, Tex. A list of the H-2-mutant lines used and references  to their first  description are 
given in Table I. 
Preparation of Cell Suspensions.  Cell  suspensions were  prepared  from  lymphoid organs as 
described previously (25) with minor modifications. Spleen or lymph node cells were mixed 
and pressed  through stainless metal sieves into RPMI-1640 medium with 25 mM Hepes buffer 
and 2 mM L-glutamine, containing 10% fetal calf serum (FCS, heat-inactivated for 30 min at 
56°C; Grand Island Biological Co.,  Grand Island, N. Y.).  This cell  suspension was washed 
twice in the same medium. 
Generation of  Killer Cells in MLC.  Spleen cells were resuspended in culture medium consisting 
of RPMI-1640 with 25 mM Hepes buffer and 2 mM L-glutamine plus 100 IU penicillin and 
100  /~g  streptomycin/ml, supplemented with  10%  heat-inactivated (30  min, 56°C)  human 
serum and containing 2-mercaptoethanol to a  final concentration of 2 ×  10  -5 M.  This cell 
suspension was used as the responding population in MLC. Viable responder cells (100 ×  106) 
were mixed with 100 ×  106 stimulator cells (irradiated with 2,500 rad from a  X3VCs source)  in 
a  250-ml culture flask  (Costar,  Data  Packaging, Cambridge, Mass.;  catalog No.  3075)  that 
contained 80 ml of culture medium. The flasks were tilted at a 45 ° angle to allow the cells to 
settle in one corner, and incubated at 37°C, after which the cells were harvested. 
CML.  After a total of 5 d of culture as described above, the cells were used as effector cells 
in CML assays.  The culture supernate was removed, the cells were  washed twice,  and were 
resuspended in medium consisting of RPMI-1640 with 25 mM Hepes, supplemented with 10% 
heat-inactivated (30 min, 56°C) FCS. 
Target cells for CML were obtained by culturing lymph node cells for 48 h in the presence 
of concanavalin A  (2.5 /zg/ml of culture medium). After one wash,  10  ×  10  ~ target  cells, 
suspended in  1 ml of wash medium, were incubated for  30 min at 37°C with  150/zCi Na2- 
[51Cr]O4 (sp  act:  50-400  mCi/mg 51Cr, The  Radiochemical Centre,  Amersham, England). 
Then the cells were washed three times and resuspended in medium with 10% heat-inactivated 
FCS. 
The CML assays  were  performed in microtiter plates with round-bottomed wells  (Cooke MELIEF,  DE WAAL, VAN r)Ea MEULEN,  MELVOLD,  AND  KOHN 
TAnLE I 
H-2K b Mutant  Lines Used in This Study 
995 
Line  H-2 haplotype  Former name(s)  First description 
B6.C-H-2  bmt  bml  H-2  ~, Hzl  Bailey and Kohn (11) 
Bailey et al. (12) 
B6-H-2  bmz  bm3  H-2  ~, M505  Egorov and Blandova (13) 
B6-H-2  bin6  bm6  H-2  ~r2  Kohn and Melvold (14) 
B6-H-2  br~  bm8  H-2  bh  Kohn and Melvold (14) 
B6.C-H-2  bin9  bm9  H-2  bi  Melvold and Kohn (15) 
B6.C-H-2  bin1°  bm 10  H-2  bj  Melvold and Kohn (15) 
B6.C-H-2 bmll  bml 1  H-2  bk  Melvold and Kohn (15) 
Additional details about these mutants have been published (19). 
Engineering Co., Alexandria, Va.). Target cells (1 X  105) were mixed with varying numbers of 
effector cells in a  total vol of 0.2 ml. The plates were incubated for 3 h at 37°C in humidified 
air with 5% COz. Subsequently, the plates were centrifuged at 700 g for  10 min. Next,  100 #1 
of the supernate was removed and transferred to a 70- X  11-mm plastic tube. The radioactivity 
in this tube was determined in a gamma scintillation counter, and the specific 51Cr release (r) 
was calculated using the formula: 
e-b 
r  --  ~  x  100%, 
s-b 
where e is the 51Cr release (counts per minute) in the experimental tube, b the background 51Cr 
release, and s the maximal release in the presence of 5% saponin. Background release was taken 
to be the 5aCr release seen in the presence of syngeneic nonactivated, cultured cells. For example, 
the background release for target cells from mouse strain A was the release seen after incubation 
of A target cells with A +  A irradiated effector cells. The background release was always <23%, 
the maximal release varied from 82 to 100% crude lysis. All assays were performed in triplicate. 
The standard error of triplicate tests was always <3% specific lysis. 
Determination of  Lymphocyte Activation in MLC.  Responding and stimulating cells from the same 
cell suspensions used for the generation of killer cells were each brought to a concentration 6f 
5 ×  106/ml.  100 #1 of responding and  100 #1 of stimulating cells were transferred to each well 
of a  round-bottomed  microculture  plate  (Cooke  Engineering Co.).  After  3  d  of culture  at 
37°C  in  humidified  air  with  5%  COz,  20  pl  [3H]thymidine  (Amersham  Corp.,  Arlington 
Heights, Ill.; 200 mCi/mmol, 20 #Ci/ml) was added. The cultures were harvested 24 h  later, 
and [3H]thymidine incorporation was determined as described previously (26).  All determina- 
tions were performed in triplicate. 
Results 
CML Reactions of Three New K b Mutants.  Three new Kb-locus mutants, all discovered 
by skin graft  rejection and proven to be gain/loss mutations of the K b locus (15,  19) 
were  tested  in CML  after MLC  with  the strain of origin, C57BL/6.  The  results are 
shown in Table II. 
As  observed  with  all  previously  studied  Kb-locus  mutants,  CML  was  strongly 
positive  in  both  directions  (Table  II),  illustrating  the  gain/loss  nature  of  these 
mutations. Proliferative responses in MLC  were also positive in both directions (Table 
II). 
Kinetics ofCML: CML Cross-Reactivity.  The definition of CML  target determinants 
specified  by the  mutations largely  depends  on  the  phenomenon  of cross-reactivity, 
i.e., lysis of target  cells of genotypes other than those of the stimulator or responder 
cell  in MLC  (third-party  targets).  An example of CML  reactions against  targets  of 996  FINE SPECIFICITY OF ALLOIMMUNE  CYTOTOXIC  T  LYMPHOCYTES 
TAaLE II 
MLC and CML Reactions of Three H-2K b Mutants  (H-2 Haplotypes bin9, bmlO, and broil) with the 
Strain of Origin, B6-H-2 b 
MLC  CML (percent specific lysis  of target cell§), H-2 
haplotype: 
H-2 haplotype  b  bm9  bml0  bml 1 
Stimu-  Re-  Proliferative  response* 
lator  sponder  111  2  3  1  2  3  1  2  3  1  2  3 
cpm ×  10  -2  SE ×  10  -e  si~ 
bm9  b  56  5  1.41  4  5  2  54  59  77 
bml0  b  108  10  2.75  4  3  67  63 
bmll  b  155  13  3.95  6  2 
b  bm9  55  4  2.18  79  37  27  9  1  0 
b  bml0  85  6  1.57  69  58  7-1 
b  bmll  159  8  2.77  84  70 
b  b  39  7 
bm9  bm9  25  4 
bml0  bml0  54  5 
bm 11  bm 11  58  9 
60  53 
3  3 
* Measured by [3H]thymidine  uptake (Materials and Methods). 
:~ si, stimulation indek: counts per minute allogeneic MLC 
counts per minute syngeneic  MLC ' using the same MLC responder. 
§ 2 ×  l0  s effector cells and 1 ×  i0  s target cells (effector:target cell ratio, 2:1). 
11 Experiment number. 
stimulator- or responder-cell genotypes and against third-party targets  is shown in 
Fig.  1.  The effector-cell number was  varied while the  target-cell number was  kept 
constant. 
Although  strongest  lysis  was  seen  against  targets  of  stimulator-cell  genotype, 
extensive cross-killing of third-party targets occurred.  Target cells of responder-cell 
genotype were,not lysed (Fig.  1). 
CML after MLC with Homozygous Responder  Cells in All Possible Combinations  of Seven K b 
Mutants  and  the  Wild-Type  H-2 b.  On  the  basis  of the  results  shown  in  Fig.  1  and 
similar results with other cell combinations (data not shown), an effector-cell number 
of 2  ×  105 was selected for optimal detection of the various levels of cross-reactivity. 
•  ,  L 
The results of CML tests after MLC with homozygous responder cells are shown in 
Table III. This analysis includes all possible unilateral MLC combinations between 
7 Kb-locus mutants and the strain of origin (B6-H-2b). 
Table III shows that lysis of target cells of MLC responder genotype never exceeded 
10%.  Therefore,  a  CML  result  was  scored  as  positive  when  -->15% specific  lysis 
occurred.  With  most  MLC  combinations, cross-killing of  third-party  targets  was 
extensive, but Usually the specific lysis of these  targets  fell below that  of targets of 
stimulator-cell genotype. These results indicate CML specificity for target  determi- 
nants of stimulator-cell genotype and extensive sharing of CML determinants between 
stimulator cells, and third-party targets. Solid line boxes indicate lysis against target 
cells of responder :genotypes (Table III). Broken line boxes indicate the only MLC MELIEF,  I~  WAAL,  VAN  DSR  MEULEN,  MELVOLD,  AND  KOHN 
T/~IGL~ CELl 
TO.  H-2 
•  •  bmlO 
.  bml 
o,  •  --~r  V'  •  •  bin3 
-s  ~  ,  1"o  /o 
No. OF EFFECTOR CELLS  x 10  .4 
FIG.  1.  Kinetics of CML cross-reactivity, bm3 anti-bm6 effector cells. 
$ 
50. 





combinations in which no killer cells were generated: bm6-anti-bm9 and vice versa 
(Table III). This indicates that bm6 and bm9 are identical for CML determinants. 
This notion is supported by the finding that  all effector-cell combinations kill bin6 
and bm9 to a similar extent. Moreover, the CML killing patterns, observed with bin6 
as stimulator or responder in MLC, were virtually identical to those observed with 
bin9 stimulator or responder cells  (see  below, Designation of CML  Determinants; 
Relatedness among Different K b Mutants). 
CML after MLC with Ft Hybrid Responder Cells in All Possible MLC Combinations of Four 
K b Mutants and the Wild-Type H-L  #.  Previous studies have indicated that CML cross- 
reactivity against third-party targets can be eliminated by introducing the third-party 
genotype into the responder cell, i.e., by using F1 hybrid responder cells  (25). The 
results of a series of CML experiments with F1 hybrid responders in MLC are shown 
in Table IV. This analysis includes all possible MLC combinations with F1 responders 
among four K b mutants  (bml, bin3, bin6, and bin8) and the wild-type H-2  b. 
Table IV shows that lysis of target cells from a parent of the F1 hybrid responder 
was  sometimes  slightly higher  than  that  of responder  type  targets  in  the  case  of 
homozygous responders (Table III), but never exceeded 18% specific lysis.  A  CML 
result achieved with Fa hybrid responding cells was scored as positive when >--20% 
specific lysis occurred. According to this criterion, a positive CML result was at least 
11% specific lysis above the highest  background lysis against  parental-type targets 
seen with the same effector cell (Table IV). 
In  all  MLC  combinations,  strong  cytotoxicity was  generated  against  ceils  of 
stimulator-cell genotype. Cross-killing against targets of the partner in the Fa responder 
was eliminated, but cross-reactivity against  other targets was still seen, though to a 
lesser extent  than  with  homozygous MLC  responders.  In  a  previous study, strong 
specific cytotoxicity was reproducibly observed against  target cells from one of the 
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stimulated  by  bm5  or  bm6  lysed  not  only  bm5  or  bm6  but  also  b  targets  (25). 
Subsequent analysis has revealed that these anomalous F1 anti-P CML reactions were 
a  result  of segregation  of a  bm5/6-1ike  mutation  in  the  H-2  b stock used  for raising 
these F1 hybrids  (C. J.  M.  Melief et  al.  Unpublished  observations.).  This has led  to 
the identification of the first  H-2 mutant  picked up by CML, that was provisionally 
named KB-96 (19). In our study, in which H-2  b stock that was free of the bmS/6-1ike 
mutation  was used  for raising F1  hybrids,  these  anomalous  CML  reactions  were no 
longer seen  (Table IV). 
Designation of CML Determinants.  The methodology by which CML  determinants 
are  identified  has  been  published  (25,  35,  36).  If a  particular  MLC  effector-cell 
combination  lyses target  cells  of stimulator-cell  genotype, then  that  target  cell,  and 
any other target cell killed to a  similar extent, are considered to express determinant 
X. Target cells that are killed less intensely but still above background are considered 
to partially express determinant X, designated as (X). Target cells that are not killed 
are considered to lack the relevant antigenic determinant.  We have arbitrarily defined 
expression of CML determinants  as follows: 
ABSENCE OF DETERMINANT.  Lysis below threshold  levels of positivity.  These levels 
are  15% specific lysis (homozygous responders,  section 3, Table III) and 20% specific 
lysis (F1 hybrid responders, section 4, Table IV). 
FULL EXPRESSION  OF DETERMINANT.  Lysis of target cells of stimulator-cell genotype. 
Lysis of other targets greater than four-fifths of this value. 
PARTIAL EXPRESSION  OF DETERMINANT.  Lysis of other targets less than four-fifths of 
this value. 
At the  1978 H-2-mutant workshop (19), a common nomenclature was agreed upon 
for the  first  20 K b CML  determinants,  4  of which  were detected  independently  by 
Forman and Klein  (23), Klein and Forman (35), and Geib et al.  (36);  and by Melief 
et al.  (24, 25). The remaining  16 determinants  were identified in our laboratory. The 
designation  of 15  of these  and  their  expression  on  4  K b mutants  and  the  strain  of 
origin, B6-H-2  b, have been published  (25). 
Table V  shows the expression of the first 20 determinants in seven Kb-locus mutants 
and B6-H-2  b. Each determinant  is defined by at least one MLC effector combination 
(Tables III and IV). Further analysis of the CML data of Tables III and IV allowed 
the  designation  of 44  new  determinants  (determinants  26-69,  2 Table  VI).  In  four 
instances,  two patterns  of expression  of a  particular  determinant  were distinguished 
(determinants  2, 5, 9, and 29; a and b). In three of these cases (determinants  2, 9, and 
29;  a  and  b),  a  slight  difference  of expression  was  found when  either  bin6  or bm9 
stimulators were used in MLC. Because of the strong evidence that bm6 and bm9 are 
identical  (Discussion), the difference in expression between determinant  a  and deter- 
minant  b  was likely a  result  of technical  variability.  In the fourth case (determinant 
5),  (bml  ×  bm3)F1  anti-b  effector cells  showed  the  same  CML  reaction  pattern  as 
(bm 1 ×  bm3)F1  anti-bm6  effector cells,  except  for bm 10 target  cells,  which showed 
full  and  partial  expression  of the  relevant  determinant,  respectively.  Because  the 
reactions against bml0 target were only performed once (Table IV) and could not be 
repeated  because  of the  lack  of available  mice,  the  5a  and  5b  determinants  are 
considered identical until proven otherwise. 
z CML determinants 21-25 were defined by J. Klein on the H-2 haplotypes f, fmb k, and kml (37). >~ 
C'4 
04 





I  ~'~'  ~  ~"  r--I  ~--  --  --, 
~-"2  I  IB 
~-*  ill 
I 
I~" ~  ~" ~1 
I  I~' 
~i~  I II 
~  I ~ 
I  I~ 
I  I~ 








e~  e~ 
Z~ 
o.  ~  _ 






~'1 ~" ~'1 
I ~  ~1 
I  I 
I 
I 
C'4  ~'11 




I  I 
I  I 
NN  N  NN 




:'4  ~ 
~  I  I~ 
"~  I  I  I 
i  I~ 
~N  N 
.~1111 
I  I  I  ~ 
I  i  ~ 
~  I  I~ 
I  I  I 




0 1006  FINE  SPECIFICITY  OF  ALLOIMMUNE  CYTOTOXIC  T  LYMPHOCYTES 
TABLE  VII 
Number of CML Mismatches and Matches with H-2 b 
A.  Matching for CML determinants defined by MLC with homozygous responders 
H-2 haplotype 
bml  bm3  bm6  bm8  bm9  bml0  bmll 
CML mismatches 
Total number of mismatches 
Type of mismatch 
+*  -  2  4  2  3  2  3  7 
(+)~  -  11  6  7  9  7  9  7 
+§  (+)  13  11  5  11  5  7  13 
26  21  14  23  14  19  27 
CML matches 
Total number of matches 
Type ofmatch 
+[]  +  0  2  5  1  5  4  0 
(+)¶  (+)  7  ll  13  9  13  9  9 
-**  -  3  1  4  3  4  4  0 
10  14  22  13  22  17  9 
Undecided  2  3  2  2  2  2  2 
Total number of CML determinants  38  38  38  38  38  38  38 
B.  Matching for all CML determinants including those defined by MLC with F~ hybrid responders 
H-2 haplotype 
bml  bm3  bm6  bm8 
CML mismatches 
Total number of mismatches 
Type of mismatch 
+*  -  9  11  7  9 
(+)~  -  18  11  17  17 
+§  (+)  17  17  5  16 
44  39  29  42 
CML matches  Type of match 
+  II  +  0  3  8  l 
(+)¶  (+)  10  13  16  11 
--**  --  8  6  9  9 
Total number of matches  18  22  33  21 
Undecided  2  3  2  3 
Total number of CML determinants  64  64  64  64 
Data compiled from Tables V and VI. 
* Difference between full expression of determinant (full  number in Tables V  and VI) and absence of 
determinant. 
:[: Difference between partial expression o~ determinant (number in parentheses) in Tables V and VI and 
absence of determinant. 
§ Difference between full and .partial expression of determinant. 
[[ Shared fully expressed determinant. 
¶ Shared partially expressed determinant. 
** Common absence of determinant. 
Relatedness among Different K b Mutants.  Two pairs of mutants  showed complete  (bm6 
and  bm9)  or extensive  (bm3  and  bml  1)  sharing  of CML  determinants.  Sharing  of 
determinants  or common  absence of a  determinant  is indicated  by boxes in Tables  V 
and VI. The  identity of bm6  and  bin9 for all CML  antigens is in agreement  with the 
observation that CML  between  these two strains is negative (section 3, Table  III) and 
that  skin grafts exchanged  between  these mutants  are permanently  accepted  (R.  W. 
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The mutants bm3 and bm 11 are closely related although not identical with respect 
to CML antigens (Tables V  and VI). This relationship is also reflected in the finding 
that most MLC combinations with either bm3 or bm 11 stimulator cells yielded strong 
CML activity against both types of target cells (Tables III, V, and VI). Furthermore, 
CML generated in reciprocal MLC between these two mutants showed little (bm 11 
anti-bm3) or no (bin3 anti-bml 1) cross-reactivity against third-party targets (Tables 
III, V, and VI; specificities 47 and 33). A  complete absence of CML cross-reactivity 
was not  observed with  any other  MLC  combination.  The nonidentity  of bm3 and 
bml 1 is  in  agreement  with  the observation  that  these  mutants  rapidly  reject  each 
others skin grafts (R. W. Melvold. Unpublished observation.). 
Distance of Each K b Mutant frorn  H-2  b.  From the CML antigen chart presented  in 
Tables V  and VI, it was determined to which extent each mutant differed from the 
strain of origin  (H-2  b)  by scoring antigen  matches and  mismatches.  In addition,  it 
was determined how many antigens were commonly lacking in both mutant and H- 
2  b" 
Matching  was  performed  in  two  ways.  First,  by matching  only  for  those  CML 
antigens  defined  by  MLC  with  homozygous  responders.  Second,  by  matching  in 
addition for those antigens defined by MLC with F1 hybrid responders. 
The  mutants  bm9,  bml0,  and  bmll  were  excluded  from  the  second  analysis, 
because in the distinction  of CML determinants by F1 hybrid responders, they were 
not  used  as  stimulators  nor as one of the  parents of the  F1  hybrid  responder.  The 
results of both ways of CML matching with H-2  b are shown in Table VII A  and B. 
Table  VII  shows  that  from  the  total  number  of matches  and  mismatches  the 
sequence  of  relatedness  with  H-2  b  is  as  follows:  bm6/bm9-bml0-bm3-bm8-bml- 
bml 1; bin6 and bin9 being the closest to H-2  b. The two mutants differing most from 
H-2  b, bml  and bml 1, do not share a  single fully expressed determinant with H-2  b, 
whereas all other mutants share one to eight fully expressed determinants with H-2  b. 
H-2  bmll appears to differ most from H-2  b, not only because it shows the largest total 
number of mismatches with H-2  b, but also because seven of these mismatches are of 
the +  ~  -  type versus only two mismatches of this type in the H-2  bm~ mutant. 
Discussion 
Three new  K b mutants,  bm9, bin10,  and  bmll,  behave in  MLC and  CML like 
other known K b mutants.  In MLC with  the strain of origin,  proliferative responses 
occur  in  both  directions  and  CTL  are  generated.  H-2  b  anti-H-2  bmx  CTL  were 
phenotypically Lyt23 and arose as a result of cooperation between Lyt 1 helper T  cells 
and Lyt23 killer T  cell precursors with possibly a  minor contribution by Lyt 123 cells 
(38). The CTL are specifically directed against the stimulator cells but, in addition, 
show  cross-killing against  several other  members of the  series  of K b mutants.  This 
indicates  that  H-2  b shares  CML  target  determinants  with  the  cross-killed  mutant 
targets which are lacking in the new mutant (MLC mutant anti-H-2  b) and that each 
new mutant shares CML target determinants with other mutants that are lacking in 
H-2  b (MLC H-2  b anti-mutant). Extensive CML cross-reactivity also occurred with all 
possible MLC  effector-cell combinations  among the  new  mutants  and  of the  new 
mutants with other K s mutants.  Exceptions were the MLC combinations bm6 anti- 
bin9 and vice versa, in which no CTL were generated, and MLC bm3 anti-bin I 1, in 
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The chart  of the  first  20  K b CML specificities,  arrived  at  during  the  1978  H-2 
mutant workshop  (19),  was confirmed with minor modifications and the three new 
mutants were typed for these determinants  (Table V). In addition, 44 new K b CML 
determinants were~identified and all seven available K b mutants were typed for these 
determinants (Table VI). 
As  discussed  previously  (23-25,  35,  36),  homozygous MLC  responders  in  many 
instances react to multiple CML determinants. This is illustrated by comparing CML 
by homozygous responders with CML by F1 hybrid responders in MLC. For example, 
b  anti-bm8 effector cells kill not only bin8 target cells, but also target cells from all 
other  haplotypes  except  that  of the  MLC  responder  (determinant  18,  Table  V). 
Effector cells  Co  ×  bml)F1  anti-bm8  kill  the  same  targets  except  for  the  reaction 
against bml which is eliminated  (determinant  19, Table V). A  further reduction  of 
cross-kill is seen with Co ×  bm6)F1 anti-bm8 effector cells (determinant  20, Table V) 
in which, apart from bin8, only bml0 and bml 1 targets are lysed. Therefore, b  anti- 
bm8 effector cells recognize at  least  three CML determinants:  one present  on bm8 
and  partially  shared  by  all  other  mutants  (determinant  18,  Table  V),  a  second 
expressed on bm8 and bm3 and  partially expressed on  all other mutants with  the 
exception  of bml  (determinant  19,  Table V),  and  a  third  expressed on  bm8 and 
partially on bml0 and bml 1 (determinant  20, Table V). Cross-killing against third- 
party targets can  also  be eliminated  by adsorption  to  third-party  monolayers  (36) 
but,  like the use of F1  hybrid responders,  this approach  is  unlikely  to eliminate all 
cross-killing, unless multiple subsequent absorptions are done. This follows from the 
following set of data.  Effector cells bm 1 anti-b kill not only b  target cells,  but  also 
targets from all other mutant lines except bml  (determinant  1, Table V). Geib et al. 
(36) have shown that the cross-reactivity against bm3 can be eliminated by absorbing 
bm 1 anti-b effector cells to bin3 monolayers (determinant 5, Table V). Determinant 
5 was found to be unique for b of the targets tested (b, bm 1, and bin3). We achieved 
the same result using (bm 1 ×  bm3)Fx responders (determinant 5, Table V). However, 
when the other targets were tested, (bin 1 ×  bin3)  anti-b effector cells still lysed bm6, 
bm9, and bm 10 targets and to a smaller extent, bm8 and bm 11  targets (Table V). It 
can  be predicted  that  bml  anti-b effectors absorbed  to bm3 monolayers show  the 
same killing pattern. 
The F1  hybrid and absorption experiments indicate  that  multiple clones of CTL 
are generated, but the actual number and specificity of all CTL clones generated in 
a given MLC can best be studied by producing monoclonal cytolytic T-cell lines (39- 
41). The possibility that even in MLC with F1 responders multiple CML determinants 
are recognized indicates that  the current  chart  of determinants  is only an approxi- 
mation of the actual situation.  The complexity of K b CML determinants calls for a 
mathematical  model  by  which  the  CML  reaction  patterns  can  be  analyzed  in  a 
systematic fashion. Recently, such a  model was developed by Wohlgemuth  (42)  and 
was applied  to the data  from which  the  first  19 CML determinants  were deduced 
(43). 
Although development of monoclonal cytolytic T  cell lines as CML-typing reagents 
and mathematical analysis of the system of K b CML determinants can be expected 
to enhance our insight into the organization of this complex immunogenetic system, 
the current chart of determinants is operationally useful for a number of deductions. 
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edness among different  mutants and concerning  the correlation  function/structure. 
The  mutants  bm6  and  bm9  show  identical  typing  for  all  64  CML  determinants 
(Tables V and VI). Two sets of additional data indicate that bm6 and bm9 are indeed 
identical. CML between these two mutants is negative in both directions (Table III) 
and both mutants share AA substitutions in the K b molecule (see above: K. Yamaga 
et al. Unpublished  observations.). Three other K b mutants are phenotypically iden- 
tical with bm6:bm5  and bm7 and the K b mutant picked up by CML, KB-96 (19). 
Together,  these mutations  form the bg-series.  (The bm5, bm6, and bm7 mutations 
were formerly called bgl, bg2, and bg3, respectively [19]). 
The  close  relationship  of  the  mutants  bm3  and  bml 1  with  respect  to  CML 
determinants  (Tables  V  and  VI)  is  likewise  matched  by a  structural  relationship. 
Others (see above: B. M. Ewenstein et al. Manuscript  in preparation; K. Yamaga et 
al.  Unpublished  observations.)  found  that  bm3  and  bml 1 share  an  identical  AA 
substitution  at position  77 of the K b molecule. A second AA substitution  at position 
89  in  the  K bin3 glycoprotein  (see  above:  B.  M.  Ewenstein  et  al.  Manuscript  in 
preparation;  K. Yamaga. Unpublished  observations.) explains why bm3 and bml 1 
also  show  CML  differences.  The  relationship  between  these  AA  substitutions  and 
CML determinants is not direct. If that were the case, bm3 anti-b effector cells should 
show  strong cross-killing of bml 1 targets  and  bm3 anti-bml 1 effector cells should 
show strong cross-killing of b  targets,  because b  and bml I  share an AA residue  at 
position 89 which  is substituted  in bm3. These predictions are not substantiated  by 
our data,  however  (Table III). Also,  it  might  be expected  that  bm3 with  two  AA 
substitutions differs more from H-2  b than bm 11 with only one AA substitution.  The 
actual analysis of relatedness indicates,  however, that bm 11  differs more from H-2  b 
than  does bm3  (Table VII). These  findings  could  signify that  CML  determinants 
reflect tertiary protein structure rather than direct AA sequences. Thus, the effects of 
the AA substitutions on the CML specificities are difficult to predict. 
The sequence of relatedness of the mutants bm6, bm3, bmS, and bml  with H-2  b 
(Table VII) is the same as that published earlier (25), except that it is now clear that 
bm3 differs more from H-2  b than does bm6. In studies on the role of the K b molecule 
in  associative recognition  and  lysis of virus-infected  target  cells by virus-specific T 
cells, it was found that the difference b ~  bm 1 completely precluded lysis in T  cell- 
target combinations that shared all other genes in the K, I-A, or I-B regions of the H- 
2 complex (28,  29).  In case of a  b  ~  bm8 or b  ~  bm5/6 difference, target-cell lysis 
was  impaired  but  not  prevented  (29).  We  have  noted  earlier  that  these  findings 
correspond with  the relatedness sequence  by CML typing with  alloreactive T  cells 
(25). 
At first sight, it seems unexpected that the difference b ~  bm 1 completely precludes 
H-2K-restricted killing in the virus systems, because bml shares  10 matches with H- 
2 b (Table VII). However, there is not a single match for fully expressed determinants 
of the type +  ~-~ +  between b and bm 1 (Table VII), whereas bm8 and bm6 show one 
and five such matches, respectively. A match for partially expressed determinants of 
the  type  (+)  ~  (+)  (Table  VII)  does  not  necessarily  indicate  antigenic  identity 
because  the  partial  lysis  could  be  directed  against  different  portions  of the  fully 
expressed determinant(s)  or against  altered  determinants.  As a  working hypothesis, 
we postulate that for the specificity of H-2 restriction in virus-directed T  cell killing, 
matching for fully expressed determinants, recognized by alloimmune CTL, is crucial, 1010  FINE  SPECIFICITY  OF  ALLOIMMUNE  CYTOTOXIC  T  LYMPHOCYTES 
whereas matching for partially expressed determinants is not important. The hypoth- 
esis predicts that in H-2K-associated killing by virus-directed T  cells, a more complete 
failure to lyse would be seen with the combinations b ~  bml  and b  ~  bml 1, than 
with the other b *-~ b  mutant combinations, a hypothesis which remains to be tested 
with the bml 1, bm3, bm9, and bml0 mutants, but so far holds for the bml, bm5/6, 
and  bm8  mutants  (29).  This  hypothesis  implies  that  at  least  some  of the  CML 
determinants recognized by alloreactive CTL are identical  to the H-2 determinants 
involved in associative recognition by virus-directed T  cells, as postulated elsewhere 
(44). 
Different compatibility requirements prevail in  H-2-associated recognition of tri- 
nitrophenyl (TNP)-modified targets, where b ~  bm 1 or b ~  bm3 differences between 
attackers and targets did not preclude H-2K-associated lysis (45),  in contrast  to the 
virus system. Perhaps in T cell killing of TNP-modified targets, the sharing of partially 
expressed determinants is sufficient. 
That  limited  AA  changes  in  the  K b  molecule  have  such  drastic  effects  on  K b- 
directed alloreactivity points out how sensitive the T  lymphocyte system is to subtle 
changes in  the  K b molecule. Indeed,  the complexity at  the target-cell  and  receptor 
levels  reported  here  may  be  a  reflection  of the  important  biological  role  of this 
category of H-2 molecule in associative recognition and elimination of virus-infected 
cells  (5-7).  In  addition,  this  complexity may help  to  explain  the  observation  that 
virus-directed cytotoxic T  lymphocytes cross-react with alloantigens (46,  47). 
Recently, it was argued that anti-H-2 CTL are less specific than the H-2-restricted 
response  to  the  male  antigen  H-Y,  because  they  show  more  cross-reactivity  (48). 
However,  the  intensity  of killing  in  the  anti-H-2  response  was  in  many  instances 
greater than in the anti-H-Y response. Therefore, cross-reactivity may have been less 
conspicuous in the anti-H-Y system. Also cross-killing in the anti-H-Y response might 
show up if more haplotypes were tested. 
The availability of the K b series of mutants has allowed recognition of individual 
determinants by exquisitely specific CTL.  The extensive cross-reactivity appears to 
indicate complexity, not lack of specificity. Comparison with the biochemical analysis 
of Brown  and  Nathenson  (20),  Nathenson  et al.  (21),  and others  (see above: B.  M. 
Ewenstein  et  al.  Manuscript  in  preparation;  and  K.  Yamaga  et  al.  Unpublished 
observations.)  shows  a  remarkable correlation  between  function  and  structure  and 
provides  further  incentives  for  study  of the  biological  role  of K  and  D  (and  L) 
molecules in alloreactivity and associative recognition. 
Summary 
The fine specificity of alloimmune cytotoxic T  lymphocytes (CTL) was investigated 
in CTL responses across the smallest known H-2 differences, those based on mutation 
at a  single H-2 locus. CTL were generated in all possible mixed lymphocyte culture 
(MLC)  combinations among seven H-2K  b mutants and  the mouse strain  of origin, 
C57BL/6 (B6-H-2b). CTL were also generated in all F1 hybrid responder/homozygous 
stimulator-cell combinations among four K b mutants  and B6-H-2  b. CTL activity was 
measured in cell-mediated lympholysis (CML) against target cells from all K b mutants 
and  B6-H-2  b.  Cross-reactivity against  targets  other  than  the  MLC  stimulator  was 
extensive and led to the distinction of 64 CML target determinants. Two K b mutants 
(B6-H-2  bm6 and B6.C-H-2  bma) showed identical typing for all 64 CML determinants. MELIEF, DE WAAL, VAN DER MEULEN,  MELVOLD,  AND KOHN  1011 
CML  reactions after  MLC  between  these  two  haplotypes were  mutually  negative. 
The mutants  B6-H-2  bins and B6.C-H-2  bmxl showed  identical typing for 47  of the 64 
determinants.  Their close relationship is in agreement  with  the finding that  H-2 bin3 
anti-H-2  bran CTL were the only ones that exclusively lysed target cells of stimulator- 
cell genotype. 
On the basis of CML  typing, the sequence of relatedness of the mutants with H-2 b 
is as follows: bm6/bm9-bml0-bm3-bm8-bml-bml  1,  bm6/bm9  being the closest to, 
and bm 11  the most distant from H-2  b. The extensive cross-reactivity of alloimmune 
CTL  appears  to  reflect  immunogenetic  complexity rather  than  lack of specificity. 
Comparison  with  other  reports  supports  the  notion  that  the  system  of K b  CML 
determinants, recognized by alloimmune CTL, is at least partially overlapping with 
the H-2K  b specificity repertoire involved in the associative T  cell recognition of virus- 
infected cells. 
We thank A. Astaldi, P. D~mant, P. Ivanyi,J. Klein, S. Nathenson, L. Nijenhuis, P. Schellekens, 
and W. Zeijlemaker for stimulating discussions and valuable suggestions. 
Received for publication  28 November 1979. 
References 
I.  Klein, J.  1975. Biology of the mouse H-2 complex. Springer-Verlag New York, Inc., New 
York.  I. 
2.  Shreffler, D. C., and C. G. David.  1975. The H-2 major histocompatibility complex and 
the immune response region: genetic variation, function and organization. Adv.  Immunol. 
70:125. 
3.  Snell, G. D., J. Dausset, and S. G. Nathenson.  1976. Histocompatibility. Academic Press, 
Inc., New York.  1. 
4.  Snell, G. D.  1978. T  cells, T-cell recognition structures and the major histocompatibility 
complex. Immunol.  Rev.  38:3. 
5.  Zinkernagel, R. M., and P. C. Doherty.  1975.  H-2 compatibility requirement for T-cell- 
mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different 
cytotoxic T-cell specifieities are associated with structures coded for in H-2K or H-2D. J. 
Exp. Med.  141:1427. 
6.  Doherty, P. C., R. V. Blanden, and R. M. Zinkernagel. 1976. Specificity of virus-immune 
effector T  cells for  H-2K or H-2D  compatible interactions:  implications for H-antigen 
diversity. Transplant.  Rev.  29:89. 
7.  Zinkernagel,  R.  M.  1978. Thymus  and  lymphohemopoietic cells:  their  role  in  T-cell 
maturation  in selection of T  cells' H-2  restriction specificity and  in  H-2-1inked Ir gene 
control. Immunol.  Rev.  42:224. 
8.  Shearer, G.  M., T. G.  Rehn,  and A. Schmitt-Verhulst.  1976. Role of the murine major 
histocompatibility  complex in the specificity of in vitro T-cell-mediated lympholysis against 
chemically modified autologous cells. Transplant.  Rev.  29:222. 
9.  Bevan,  M. J.  1975. The  major histocompatibility complex determines susceptibility to 
cytotoxic T  cells directed against minor histocompatibility antigens.J. Exp. Med.  142:1349. 
10.  Simpson, E., and R. D. Gordon. 1977. Responsiveness to HY antigen. Ir gene complemen- 
tation and target-cell specificity. Immunol.  Rev.  35:59. 
11.  Bailey, D. W., and H. I. Kohn.  1965. Inherited histocompatibility changes in progeny of 
irradiated and unirradiated mice. Genet. Res. 6:330. 
12.  Bailey, D. W., G. D. Snell, and M. Cherry. 1971. Complementation and serological analysis 
of an H-2 mutant. In Proceedings of the Symposium on Immunogenetics of the H-2 system. 
A. Lengerovfi and M. Vojtiskovfi, editors. S. Karger AG, Basel. 155. 1012  FINE SPECIFICITY OF ALLOIMMUNE CYTOTOXIC  T  LYMPHOCYTES 
13.  Egorov, I. K., and Z. K. Blandova. 1968. The genetic homogeneity of the inbred mice bred 
at  the  Stolbosaya  farm.  II.  Skin  grafting  tests.  Genetika.  12:63. (In  Russian,  English 
summary.) 
14.  Kohn, H. I., and R. W. Melvold. 1974. Spontaneous histocompatibility  mutations detected 
by dermal grafts:  significant changes in rate over a  10-year period in the mouse system. 
Murat. Res. 24:163. 
15.  Melvold, R. W., and H. I. Kohn. 1976. Eight new histocompatibility mutations associated 
with the H-2 complex, lmmunogenetics. 3:185. 
16.  Egorov,  I.  K.  1974. Genetic control  of  H-2  alloantigens as  inferred  from  analysis of 
mutations, lmmunogenetics. 1:97. 
17.  McKenzie, I. F. C., T. Pang, and R. V. Blanden. 1977. The use of H-2 mutants as models 
for the study of T-cell activation, lmmunol. Reo. 35:181. 
18.  Klein,  J.  1978. H-2 mutations: their genetics and effect on immune functions. Adv. lrnmunol. 
26:55. 
19.  Kohn, H. I.,J. Klein, R. W. Melvold, S. G. Nathenson, D. Pious, and D. C. Shreffler.  1978. 
The first H-2 mutant workshop.  Immunogenetics. 7:279. 
20.  Brown,J. L., and S. G. Nathenson. 1977. Structural differences between parent and mutant 
H-2K glycoproteins from two H-2K gene mutants: B6.C-H-2  ba (Hzl) and B6-H-2  ~  (M505). 
J. lmmunol. 118:98. 
21.  Nathenson, S. G., B. M. Ewenstein, H. Uehara, J. M. Martinko, J. E. Coligan, and T. J. 
Kindt. Structure of H-2 major histocompatibility complex products: recent studies on the 
H-2K  b glycoprotein and on the H-2K  b MHC mutants. In Current Trends in Histocompat- 
ibility. S.  Ferrone and R. A.  Reisfeld, editors.  Plenum Publishing Corp., New York.  In 
press. 
22.  Widmer, M. B., B.J. Alter, F. H. Bach, M. L. Bach, and D. W. Bailey.  1973. Lymphocyte 
reactivity to serologically undetected components of the major histocompatibility  complex. 
Nat. New Biol. 242:239. 
23.  Forman, J., and J. Klein. 1975. Analysis of H-2 mutants: evidence for multiple CML target 
specificities controlled by the H-2K  b gene. Immunogenetics. 1:469. 
24.  Melief,  C.  J.  M.,  R.  S.  Schwartz,  H.  I.  Kohn,  and  R.  Vq.  Melvold.  1975. Dermal 
histocompatibility and in vitro lymphocyte reactions of three new H-2 mutants. Immunoge- 
netics. 2:337. 
25.  Melief, C. J. M., M. Y. van der Meulen, and P. Postma. 1977. CML typing of serologically 
identical H-2 mutants. Irnrnunogenetics. 5:43. 
26.  Klein, J.,  and I.  K.  Egorov.  1973. Graft-versus-host reactions with  an  H-2  mutant. ,]. 
Iramunol. 111:976. 
27.  Egorov,  I.  K.,  Y.  A.  Mnatsakanyan, and  L.  E.  Pospelov.  1977. Do  histocompatibility 
antigens recognize themselves?  lmmunogenetics. 5:65. 
28.  Zinkernagel, R. M.  1976. H-2 compatibility requirement for virus-specific T-cell-mediated 
cytolysis.  The  H-2K structure involved is coded  by a  single cistron defined by H-2K  b 
mutant mice.]. Exp.  med.  145:437. 
29.  Blanden, R. V., M. B. C. Dunlop, P. C. Doherty, H. I. Kohn, and I. F. C. McKenzie. 1976. 
Effects of four H-2K mutations on virus-induced antigens recognized by cytotoxic T  cells. 
Immunogenetics. 3:541. 
30.  Zinkernagel, R. M., P. A. Klein, andJ. Klein. 1978. Host-determined T-cell fine specificity 
for self-H-2 in radiation bone-marrow chimeras of standard C57BL/6 (H-2b), mutant Hz 1 
(H-2~), and F1 mice. Immunogenetics. 7:73. 
31.  Klein, J., M. Hauptfeld, and V. Hauptfeld. 1974. Serological distinction of mutants B6.C- 
H(zl) and B6.M505 from strain C57BL/6.J. Exp.  Med.  140:1127. 
32.  Egorov,  I. K., L. E. Pospelov,  V. N. Shkurko, Y. A. Mnatsakanyan, and E. Y. Khodjaev. 
1979. Study of H-2 mutations in mice. VIII. Aberrant expression of H-2.5 antigen on red 
blood cells of H-2  b mutants. Immunogenetics. 8:161. MELIEF, t~E WAAL, VAN DER MEULEN,  MELVOLD, AND KOHN  1013 
33.  McKenzie, I. F. C., G. M. Morgan, R. W. Melvold, and H. I. Kohn.  1976. Serological and 
complementation studies in four C57BL/6 H-2 mutants, lmmunogenetics.  3:241. 
34.  Berke, G.,  and  D.  B.  Amos.  1973. Cytotoxic lymphocytes in  the absence of detectable 
antibody. Nat. New Biol.  242:237. 
35.  Klein, J., and J. Forman.  1976. What can one learn about lymphocytes by studying H-2 
mutations? Proc. Leukocyte  Cult.  Conf.  10:443. 
36.  Geib, R., C. Chiang, and J. Klein. 1978. Evidence for multiple clones of cytotoxic T  cells 
responding to antigenic determinants on the same motecule.J, lmmunol.  120:340. 
37.  Klein, J.  1979. Allograft reaction: atavism or immunological tour de force? 1NSERM (lnst. 
Natl. Sante  Rech.  Med.).  Symp.  10:241. 
38.  Melief, C. J.  M.,  M.  Y.  van  der  Meulen,  B.  J.  Christiaans,  and  P.  de  Greeve.  1979. 
Cooperation between subclasses of T  lymphocytes in the in vitro generation of cytotoxicity 
against a mutant H-2K difference. An analysis with anti-Lyt antisera. Eur. J. lmmunol.  9:7. 
39.  Gillis, S., P. E. Baker, F. W. Ruscetti, and K. A. Smith. 1978. Long-term culture of human 
antigen-specific cytotoxic T-cell lines. J. Exp. Med.  148:1093. 
40.  Nabholz, M.,  H.  D.  Engers, D.  Collavo, and  M.  North.  1978. Cloned T-cell lines with 
specific cytolytic activity. Curt.  Top.  Microbiol.  lmmunol.  81:176. 
41.  von Boehmer, H., H. Hengartner, M. Nabholz, W. Lernhardt, M. Schreier, and W. Haas. 
1979. Fine specificity of a continuously growing killer cell clone specific for H-Y antigen. 
Eur. J. lmrnunol. 9:592. 
42.  Wohlgemuth, A. 1978. Abstract immunogenetic systems.,]. Theor. Biol.  73:469. 
43.  Wohlgemuth, A. 1978. Matrix techniques applied to CML-typed H-2 mutants, lrnmunoge- 
netics. 7:379. 
44.  Fischer-Lindahl, K.  1978.  Antigen recognition by cytotoxic T  lymphocytes. In Cytotoxic 
Cell Interaction and Immunostimulation. G. RiethmiJller, P. Wernet and G. Cudkowicz, 
editors. Academic Press, Inc., New York.  117. 
45.  Forman, J., and J. Klein. 1977. Immunogenetic analysis of H-2 mutations. VI. Crossreac- 
tivity in cell-mediated lympholysis between TNP-modified cells from H-2 mutant strains. 
Irnmunogenetics. 4:183. 
46.  Finberg, R., S. J. Burakoff, H. Cantor, and B. Benacerraf.  1978. Biological significance of 
alloreactivity: T  cells stimulated by Sendai virus-coated syngeneic cells specifically lyse 
allogeneic target cells. Proc. Natl. Acad.  Sci.  U. S. A. 75:5145. 
47.  Koszinowski, U., D. Greber, and I. Neuschaefer-Rube.  1979. Generation of virus-specific 
cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive 
cytotoxic T  cells. Z. lrnmunitaetsforsch.  156:83. 
48.  Simpson, E., L. Mobraaten, P. Chandler, C. Hetherington, M. Hurme, C. Brunner, and D. 
Bailey. 1978. Cross-reactive cytotoxic responses. H-2 restricted are more specific than anti- 
H-2 responses.J. Exp. Med.  148:1478. 